US15119A2024

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate UpdateAkari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

April 16, 2025 08:00 ET  | Source: Akari Therapeutics Plc Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to…

4 weeks ago
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial OfficerAkari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

BOSTON and LONDON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) today announced the appointment of Torsten…

5 months ago